A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma
2021
Zhongliu Fangzhi Yanjiu
Preserved Fulltext
Intrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets have been found. This article will review the novel potential therapeutic targets of ICC.
doi:10.3971/j.issn.1000-8578.2021.20.1248
doaj:80fb895dfc274f1698c83af55269ba9d
fatcat:ezcv3mezwvelzhbdcvlurhfzry